Core Scientific, Inc.
CORZ
$14.53
$0.402.83%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 31.25% | -17.83% | |||
| Total Other Revenue | -7.08% | -15.92% | |||
| Total Revenue | -1.13% | -16.22% | |||
| Cost of Revenue | 3.21% | -16.95% | |||
| Gross Profit | -38.82% | -9.37% | |||
| SG&A Expenses | 41.94% | -6.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -378.79% | 1,227.70% | |||
| Total Operating Expenses | -17.50% | -9.25% | |||
| Operating Income | 48.07% | -7.46% | |||
| Income Before Tax | -261.24% | 319.07% | |||
| Income Tax Expenses | -22.93% | -45.33% | |||
| Earnings from Continuing Operations | -261.32% | 318.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -261.32% | 318.68% | |||
| EBIT | 48.07% | -7.46% | |||
| EBITDA | 85.29% | -68.17% | |||
| EPS Basic | 75.54% | 71.75% | |||
| Normalized Basic EPS | -258.88% | 309.59% | |||
| EPS Diluted | 75.54% | 71.75% | |||
| Normalized Diluted EPS | -258.88% | 309.59% | |||
| Average Basic Shares Outstanding | 0.88% | 2.96% | |||
| Average Diluted Shares Outstanding | 0.88% | 2.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||